Bromodomain Inhibition Reveals FGF15/19 As a Target of Epigenetic Regulation and Metabolic Control is a research paper published in Diabetes (2022). On theSindex it has a DataRank of 0.548. It has been cited 10 times, with 10 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.360
From this paper's citation signal
Citation Network Contribution
0.188
From 8 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 10 citers.
NCI NIH HHS
Grant: P01 CA142106
NICHD NIH HHS
Grant: P50 HD093540
NIDDK NIH HHS
Grant: R01 DK099511
NIDDK NIH HHS
Grant: R01 DK106193
NICHD NIH HHS
Grant: U54 HD093540
NCI NIH HHS
Grant: P30 CA008748
NIDDK NIH HHS
Grant: P30 DK036836
NICHD NIH HHS
Grant: R01 HD038540
NIDDK NIH HHS
Grant: R01 DK101043
FWCI
0.67
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals